Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the control of metabolic disorders. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://violasxgx401333.blogozz.com/37899838/retaglutide-a-promising-glp-1-receptor-agonist